HomeCYTH • NASDAQ
add
Cyclo Therapeutics Inc
Previous close
$1.29
Day range
$1.27 - $1.31
Year range
$0.83 - $2.57
Market cap
37.04M USD
Avg Volume
158.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 311.40K | 66.70% |
Operating expense | 5.93M | 15.14% |
Net income | -5.64M | -13.29% |
Net profit margin | -1.81K | 32.04% |
Earnings per share | — | — |
EBITDA | -5.64M | -13.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.25M | 499.10% |
Total assets | 13.25M | 214.28% |
Total liabilities | 8.49M | 143.93% |
Total equity | 4.76M | — |
Shares outstanding | 28.72M | — |
Price to book | 7.59 | — |
Return on assets | -149.71% | — |
Return on capital | -589.89% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.64M | -13.29% |
Cash from operations | -4.29M | -56.36% |
Cash from investing | -2.42K | — |
Cash from financing | 11.74M | — |
Net change in cash | 7.44M | 371.04% |
Free cash flow | -1.78M | -101.78% |
About
Founded
1990
Headquarters
Website
Employees
8